ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Neurology

Top Neurology Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RICHARD STAPPENBECK M.D.

Neurology

10,967

$757K

330
117 are 65+

48%
patients receiving schedule two controlled substances

Avg: 3%

54%
patients receiving schedule three controlled substances

Avg: 5%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $192

KENNETH LAZARUS MD,PHD

Neurology

9,951

$1.22M

628
313 are 65+

30%
patients receiving schedule two controlled substances

Avg: 3%

26%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$123
Average prescription price

Avg: $192

MICHAEL TAORMINA M.D.

Neurology

9,076

$1.64M

750
494 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$181
Average prescription price

Avg: $192

PETER LEE M.D.

Neurology

8,574

$566K

535
199 are 65+

22%
patients receiving schedule two controlled substances

Avg: 3%

34%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $192

SCOTT COOPER M.D.

Neurology

7,194

$1.29M

605
492 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 24%

$180
Average prescription price

Avg: $192

VIRENDRA RANADIVE MD

Neurology

6,767

$923K

659
534 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$136
Average prescription price

Avg: $192

BEN THROWER MD

Neurology

6,612

$6.06M

351
59 are 65+

14%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 24%

$917
Average prescription price

Avg: $192

DOUGLAS STUART M.D.

Neurology

6,606

$2.6M

474
275 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$394
Average prescription price

Avg: $192

HUSHAM MISHU MD

Neurology

5,933

$1.69M

438
223 are 65+

21%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 24%

$285
Average prescription price

Avg: $192

KALPESH PATEL M.D.

Neurology

5,697

$591K

743
433 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$104
Average prescription price

Avg: $192

WILLIAM NAGUSZEWSKI M.D.

Neurology

5,557

$789K

497
253 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$142
Average prescription price

Avg: $192

JEFFREY GLASS MD

Neurology

5,431

$716K

501
266 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$132
Average prescription price

Avg: $192

EDWARD NOVEY M.D.

Neurology

5,334

$1.06M

572
351 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$198
Average prescription price

Avg: $192

HERNAN POSAS M.D.

Neurology

5,112

$927K

367
212 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$181
Average prescription price

Avg: $192

RAMON SANCHEZ M.D.

Neurology

4,952

$828K

325
205 are 65+

17%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$167
Average prescription price

Avg: $192

ROZA ADAMCZYK MD

Neurology

4,944

$1.35M

323
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 24%

$273
Average prescription price

Avg: $192

BIPIN PATEL M.D.

Neurology

4,933

$350K

498
309 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $192

RICHARD BODZINER M.D.

Neurology

4,898

$1M

516
388 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$205
Average prescription price

Avg: $192

MAHMOOD EISA MD

Neurology

4,688

$713K

476
321 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

2%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$152
Average prescription price

Avg: $192

JAGDISH SIDHPURA MD

Neurology

4,644

$1.05M

474
275 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$225
Average prescription price

Avg: $192

JULIA MIKELL M.D.

Neurology

4,552

$1.12M

539
374 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$247
Average prescription price

Avg: $192

ANTHONY MURRO MD

Neurology

4,509

$570K

329
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$126
Average prescription price

Avg: $192

MICHAEL BAKER M.D.

Neurology

4,474

$615K

422
273 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$137
Average prescription price

Avg: $192

QING NI M.D.

Neurology

4,246

$531K

424
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$125
Average prescription price

Avg: $192

BRAD LINDSEY MD

Neurology

4,058

$657K

326
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$162
Average prescription price

Avg: $192

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank